World Federation of Hemophilia/LinkedIn
Oct 30, 2025, 06:57
For People on Emicizumab, the Use of a aPCC Raises Critical Clinical Questions
World Federation of Hemophilia shared a post on LinkedIn:
“For people on emicizumab, the use of activated prothrombin complex concentrate (aPCC) raises critical clinical questions. A new article bridges evidence with real-world practice to guide safer, smarter care decisions.”
Title: Activated prothrombin complex concentrate in patients receiving emicizumab prophylaxis: from evidence to clinical practice
Authors: Robert F. Sidonio, Jr., Guy Young, Carmen Escuriola Ettingshausen, Johnny Mahlangu, Margareth C. Ozelo, Alok Srivastava, Jerzy Windyga, Hye–Youn Lee, Aurelia Lelli, Steven W. Pipe
Read full article here.
Stay informed with Hemostasis Today.
activated prothrombin complex concentrate (aPCC)
Alok Srivastava
Aurelia Lelli
Carmen Escuriola Ettingshausen
Emicizumab
Guy Young
Health
Hematology
Hemostasis
Hemostasis Today
Hye–Youn Lee
Jerzy Windyga
Johnny Mahlangu
Jr.
Margareth C. Ozelo
Medicine
Robert F. Sidonio
rpth
Steven W. Pipe
World Federation of Hemophilia
-
Jun 4, 2026, 13:23How Access to Care Changed One Life – WFH
-
Jun 4, 2026, 13:16Muhammad Usman Arshad: Meta-Analysis Supports Expanding Role of DOACs in Cancer-Associated Thromboembolism
-
Jun 4, 2026, 12:59Dual Prognostic Significance of P2RY12 in Antithrombotic-Treated STEMI – JTH
-
Jun 4, 2026, 12:43Beth Wallace: Raising Awareness of Hereditary Haemochromatosis
-
Jun 4, 2026, 11:57José María Bastida Bermejo: IPDs Help to Better Understand Platelet Biogenesis and Function
-
Jun 4, 2026, 11:07Cristina Pecorilla: PSG6 and A New Approach to Cancer-Associated Thrombosis
-
Jun 4, 2026, 10:55Jacqui McCallum: Stroke Foundation Brings Stroke Advocacy to State Parliaments
-
Jun 4, 2026, 10:47Eugene Tang: Do Dementia-Predicting Scores Work for Stroke Patients?
-
Jun 4, 2026, 10:392026 National Stroke Awards Nominations Are Now Open – Stroke Foundation